Enteral exposure of suckling rats to phytohaemagglutinin (PHA) has been shown to induce growth and precocious functional maturation of the gastrointestinal tract. The aim of the present study was to explore the mechanism of this action. Suckling rats, 14 d old, were fed a single dose of PHA (0·05 mg/g body weight) or saline. The binding of PHA to the gut epithelium and its effect on the morphology and functional properties of the gut and pancreas were studied up to 3 d after treatment. Initially, at 1-24 h, the PHA bound along the gut mucosal lining, resulting in disturbed gut morphology with villi shortening and rapid decreases in disaccharidase activities and macromolecular absorption capacity. During a later phase, between 1 and 3 d, the PHA binding had declined, and an uptake by enterocytes was observed. An increase in crypt cell proliferation and gut growth became evident during this period, together with a functional maturation, as indicated by increases in disaccharidase (maltase and sucrase) activities and the low macromolecular absorption capacity. Pancreas growth also increased, as did its content of digestive enzymes. We conclude that enteral exposure to PHA in suckling rats temporarily causes mucosal disarrangement and functional impediment of the gut, which may be explained by binding to and disruption of the gut mucosa and a two-fold increase in the plasma corticosterone concentration. These findings may lead to a better understanding of the role of diet in gastrointestinal maturation and may constitute a basis for the treatment of mammals having an immature gut.
During the third postnatal week, coinciding with natural weaning, the rat gut undergoes prominent maturational changes that irreversibly adapt it for the digestion and absorption of the weaning diet. These ontogenetic changes appear to be genetically programmed, although various environmental stimuli, such as gut luminal factors and hormonal mediators, may influence its temporal progress (Lee & Lebenthal, 1983; Henning et al. 1994; Pacha, 2000) . Previous studies have shown that lectins, which are essential parts of dietary plants, may affect the gut (Pusztai et al. 1990; Bardocz et al. 1996) . Thus, enteral provocation with the red kidney bean (Phaseolus vulgaris) lectin, phytohaemagglutinin (PHA), for a 3 d period in rats between 14 and 16 d of age, resulted in a more mature gut epithelium with altered disaccharidase pattern (i.e. decreased lactase and increased maltase and sucrase activities) and reduced macromolecular absorption capacity (i.e. gut closure; Linderoth et al. 2005) , which in the rat normally occurs at weaning (Telemo et al. 1987) . Furthermore, provocation with PHA also affected the rat pancreas, leading to an increase in its weight relative to body weight (BW) and enhanced exocrine function (Linderoth et al. 2005) .
Although the effects of PHA are evident, the mechanism of action of PHA on the immature rat intestine is not known. Studies in adult rats have shown that PHA can bind specifically to brush-border glucoconjugates of the gut epithelial cells (Cummings & Kornfeld, 1982; Green & Baenziger, 1987) . This observation suggests that there is a direct mitogenic effect of PHA on the enterocytes, with an accelerated proliferation as a consequence (Otte et al. 2001) ; this correlates well with the strong trophic effects observed after enteral exposure. However, the ingestion of PHA may also have an indirect action, since the stimulation of pancreatic secretion and growth Herzig et al. 1997; Pusztai, 1999) may in part be due to the release of gut peptide hormones, e.g. cholecystokinin and enteroglucagon (Herzig et al. 1997; Grant et al. 1999 Grant et al. , 2000 . In addition, PHA is reported to be transported by endocytosis through the epithelial mucosa to the general circulation, and thus may in this way contribute in a direct manner to the systemic effects (Pusztai, 1989 (Pusztai, , 1993 .
The aim of the present study was to investigate further how the intestinal provocation by PHA induces functional maturation of the gastrointestinal tract in suckling rats. Alterations taken as evidence for gut maturation were foremost functional changes, such as decreased macromolecular transmission capacity, a shift in expression of the intestinal disaccharidases towards an adult pattern and an increase in pancreas enzymes.
In addition, in the distal small gut, the replacement of the fetal type of enterocytes containing supranuclear vacuoles with adult-type enterocytes, which lack such vacuoles, was also taken as verification that the maturation process had been initiated. The binding of PHA to the gastrointestinal tract and its effect on enterocyte proliferation, small intestinal morphology, and gut and pancreas function were studied in the animals between 1 h and up to 3 d after PHA treatment. These effects were related to changes in the plasma levels of two different hormones claimed to be involved in postnatal gut maturation in the rat, corticosterone and insulin.
Materials and methods

Animals
The study was performed in rats (Rattus norvegicus) of the Sprague-Dawley stock (Mol:SPRD Han; Taconic M & B A/S, Ry, Denmark), conventionally bred in the departmental animal unit under a controlled environment at a temperature of 20^18C, a relative humidity of 50^10 % and a 12 h light-12 h dark cycle. Each dam with her litter was housed individually in a polycarbonate cage (Macrolon w III; Bayer, Leverkusen, Germany) on chopped aspen wood bedding (Beekay; B & K Universal AB, Sollentuna, Sweden), with free access to tap water and a breeding chow (Rat & mouse autoclavable diet; B & K Universal AB) dispensed from a lidded feed hopper. All the pups were kept with their dams and were allowed to suckle freely during the whole experimental period. The birth date of the pups was designated as day 0, and within 2 d after birth the litter sizes were restricted to ten to thirteen pups each. The study was approved by the Lund University Ethical Review Committee for Animal Experiments and conducted according to European Community regulations concerning the protection of experimental animals.
Preparation of phytohaemagglutinin
Red kidney bean (P. vulgaris) lectin, PHA, was purified by affinity chromatography on Fetuin-Sepharose-4B as described previously (Herzig et al. 1997) . In short, red kidney bean albumins were extracted with acetic acid from finely ground kidney beans, concentrated by ultrafiltration and dialysed against Tris -HCl buffer, pH 7·6 (Pusztai & Watt, 1974) . This preparation was then applied on a Fetuin-Sepharose column and washed with the Tris -HCl buffer, after which the bound PHA was eluted with a 0·05-M glycine -HCl buffer, pH 2·5, containing 0·2-M NaCl, dialysed against distilled water, and freeze-dried. The PHA preparation was pure by the criterion of producing a single protein band on PAGE.
Experimental procedures
In a set of three experiments, the pups in each litter (n 17 litters) were weighed and divided into treatment (n 134) and control (n 84) groups in a split-litter mode (Linderoth et al. 2005) . At 07.00 hours, the 14-d-old pups were gavage-fed a single dose of PHA (0·05 mg/g BW) dissolved in saline (0·9 % NaCl) using a feeding tube (0·96 mm outer diameter, PE50; Becton Dickinson, Sparks, MD, USA), while the controls received the vehicle saline (0·01 ml/g BW) in a corresponding manner.
In the first experiment, at 1, 3, 6, 12, 24, 48 and 72 h after the PHA gavage, the pups were separated from their dams and anaesthetized by light sedation in a CO 2 atmosphere prior to receiving a subcutaneous injection of a mixture of azaperone (Stresnil w , 30 mg/g BW; Janssen-Cilag, Vienna, Austria) and ketamin (Ketalar w , 170 mg/g BW; Pfizer, Täby, Sweden) prior to sacrifice. The abdomen and thorax were then opened and blood (0·5-1·0 ml) was collected by heart puncture into ice-chilled tubes containing1·5 mg EDTA and 20 000 IU aprotinin (Trasylol w ; Bayer, Leverkusen, Germany). Plasma was obtained after centrifugation at 3000 g for 15 min at 48C and stored at 2 708C until analyses. After this the entire pancreas was removed by dissection. The small intestine, from the pylorus to the ileocaecal junction, was removed and placed on a non-absorbent surface, taking care not to stretch it, and its length was measured. The small intestine was then divided into a proximal and a distal portion of equal length and the contents were flushed out with 1 ml ice-cold saline. The pancreas and small intestinal portions were weighed, frozen on dry ice and then stored at 2 708C until analysis. Finally, the stomach (after opening and rinsing with ice-cold saline to remove its contents), spleen, liver and thymus were dissected out and weighed.
In the second experiment, 14-d-old pups were divided into a PHA and a control group and thereafter treated and sacrificed as described above. For histological analyses, 1-cm-long segments were collected from the midsection of the proximal and distal portions of the small intestine, and samples were obtained from the stomach, pancreas, spleen and thymus. These samples were fixed in Bouin's solution for 24 h, and then stored in 70 % ethanol until further processing.
In the third experiment, 14-d-old pups were divided into a PHA and a control group and thereafter treated as described previously. At 1, 6, 24, 48 and 72 h after the PHA exposure the pups were also gavage-fed a marker molecule solution (0·025 ml/g BW) containing bovine serum albumin (BSA; 1·25 mg/g BW) and bovine IgG (BIgG; 1·25 mg/g BW) in saline. Prior to administration, the pups had been separated from their dams for 1 h. Three hours after the marker solution administration, the animals were anaesthetized and blood was collected as described above.
Measurements
Histology. The fixed histological samples were embedded in paraffin, cut into sections 5 mm thick according to standard procedures, and stained by haematoxylin and eosin. Then, using light microscopy, the villus height and the crypt depth and width, and the small intestinal diameter (here defined as the total diameter minus the luminal diameter) were measured.
For the immunohistochemical analysis of crypt cell proliferation, the small intestinal segments were blocked for endogenous peroxidase activity, and stained using mouse monoclonal antibody against proliferating cell nuclear antigen (PCNA; DAKO A/S, Copenhagen, Denmark) as the primary antibody and goat anti-mouse horseradish peroxidase-conjugated antibodies (DAKO A/S) as the secondary antibody. To visualize the peroxidase activity, a 0·05 % solution of 3,3-diaminobenzidine tetrahydrochloride (Sigma Chemicals, St. Louis, MO, USA) was used as the substrate and the sections were counter-stained with haematoxylin, dehydrated and mounted in DPX media (BDH Chemicals Ltd, Poole, UK). The stained tissue samples were imaged using an Olympus PROVIS microscope and an Olympus DP50 camera (Olympus, Tokyo, Japan), and thereafter processed to detect the number of PCNA þ cells in the crypt zone using the ImageJ software package (version 1.32; National Institutes of Health, Bethesda, MD, USA). The results were quantified by counting the numbers of PCNA þ and PCNA 2 epithelial cells in eight to ten crypts from each portion of the small intestine (Bravo & Macdonald-Bravo, 1987; Sheen-Chen et al. 2003) .
The tissue binding of PHA was evaluated by immunohistochemical analysis using a rabbit antiserum against P. vulgaris agglutinin (E þ L; Vector Laboratories, Burlingame, CA, USA), at dilution 1:5000, as the primary antibody and goat anti-rabbit horseradish peroxidase-conjugated antibodies (DAKO A/S) as the secondary antibody. Visualization and imaging followed the same procedures as for the immunohistochemical analysis of crypt cell proliferation. Tissue samples from the control (saline-treated) rats were used to exclude non-specific binding of the primary antibody. In addition, for all immunohistochemical analyses, IgG controls were run to check for non-specific binding of the horseradish peroxidase-conjugated secondary antibodies. To do so, the sections were incubated with 1 % BSA in 0·02-M PBS instead of the primary antibody. The secondary horseradish peroxidase-conjugated antibodies were used in working dilution according to standard procedures. The staining reaction between the primary and secondary antibody was regarded as specific if the reaction with the secondary antibody alone was negative.
Intestinal and pancreatic enzymology. The proximal portion of the small intestine was thawed and homogenized in ice-cold 0·9 % NaCl (1:10 w/v) using a glass homogenizer. The disaccharidase activities (i.e. maltase, sucrase and lactase) were measured by incubating the homogenates with the appropriate disaccharide for 1 h, after which the liberated glucose was measured using a glucose oxidase reagent (Sigma Chemicals), in accordance with the assay of Dahlqvist (1984) . The protein contents of the intestinal homogenates were determined by the method of Lowry et al. (1951) , modified for 96-well microplates (Pierzynowski et al. 1990) , and using purified BSA (Sigma Chemicals) as the standard.
The pancreas was homogenized in ice-cold 0·2-M Tris -HCl buffer þ 0·05-M CaCl 2 , pH 7·8 (1:10 w/v) using a glass homogenizer, and centrifuged at 15 000g for 20 min at 4 8C. The protein contents in the supernatants were determined according to Lowry et al. (1951) . After activation with enteropeptidase (Sigma Chemicals), the trypsin activity in the supernatants was determined spectrophotometrically with a microplate modification (Pierzynowski et al. 1990 ) of the original method of Fritz et al. (1966) , using benzoyl-DL-argininep-nitroanilide (Sigma Chemicals) as the substrate. The amylase activity was analysed using Ethylidene-pNP-G7 as the substrate (Infinitye Amylase Liquid Stable Reagent; Thermo Electron, Victoria, Australia), according to the manufacturer's instructions.
Plasma concentrations of marker molecules. The plasma levels of the marker molecules at 3 h after gavage feeding were quantified by electroimmunoassay (Laurell, 1972) . The BSA assay was performed using purified BSA (Sigma Chemicals) as the standard, and anti-BSA (DAKO A/S) as the precipitating antibody. The BIgG concentration was determined using purified BIgG (Sigma Chemicals) as the standard, and anti-BIgG (ICN Biomedicals, Costa Mesa, CA, USA) as the antibody.
Plasma concentrations of hormones. The plasma levels of corticosterone were quantified using a solid-phase 125 I RIA (Coat-A-Count w rat corticosterone kit; Diagnostic Products Corporation, Los Angeles, CA, USA) designed for quantitatively measuring total corticosterone in rat serum, according to the manufacturer's instructions. The antiserum used was highly specific for rat corticosterone with a low risk for cross-reactivity, and concentrations as low as 5·7 ng/ml could be detected.
Plasma insulin was determined with RIA using a guinea-pig anti-rat insulin antibody, 125 I-labelled human insulin as a tracer, and rat insulin as the standard (Linco Research, St Charles, MO, USA).
Statistical analyses
To compensate for individual variations in BW, the organ measurements and the pancreas parameters are presented per g BW. All data are presented as means and standard deviations. Statistical comparisons between PHA-treated and their time-matched littermate control rats were carried out using the unpaired t test (Sigma Stat software package version 2.03; SPSS Inc., Chicago, IL, USA). Differences were considered to be significant when P, 0·05.
Results
After exposure to a single dose of PHA by gavage feeding, the 14-d-old suckling rats were examined to determine the binding and functional effects of PHA on the gut during the period from 1 to 72 h after administration. In addition, the effect on the pancreas and the influence on plasma concentrations of corticosteroids and insulin were evaluated.
Immunohistochemical localization of phytohaemagglutinin
PHA could not be detected in any of the controls (results not shown), while at 1 h after gavage feeding, PHA was detected along the stomach and intestinal epithelium, in both the proximal and the distal intestinal regions, of the PHA-treated pups ( Fig. 1(A-C) ). The staining was confined to the brush-border region of the epithelial cells along the villus from its tip to the crypt-villus junction, but not in the crypt region. Later, at 3 to 6 h after PHA exposure, the general pattern of staining was similar, but there was an increase in the intensity and extent of the PHA staining down along the stomach glands. Between 12 and 24 h, the staining in the stomach had subsided, but it was still visible in the small intestine ( Fig. 1(D-F) ). At 12 h after exposure, stained PHA granules could be seen in the enterocytes in the proximal portion of the intestine ( Fig. 1(E) ), and by 24 h (results not shown) in the distal portion. By 72 h, the presence of PHA was no longer detectable in the stomach, but it could still be seen on the upper half of the small intestinal villi. In addition, PHA could be found on the basolateral side of the enterocytes and in the lamina propria ( Fig. 1(G -I) ). In contrast to the observations in the gut, staining indicating the presence of PHA could not be detected in any of the extraintestinal sites, such as the pancreas, liver, kidney, thymus or spleen, at 1-72 h after the PHA treatment.
Effect on body and organ growth
The gavage feeding with PHA had no effect on the BW gains of the pups compared with their age-matched controls (Table 1) . However, at necropsy at 3 and 6 h after treatment, but not at 1 h or at 12 h and thereafter, the intestine appeared to be slack and fragile, and was filled with fluid. These observations did not coincide with any statistically significant changes in the small intestinal length and weight, or with changes in the weights of the stomach, liver and pancreas. By 24 h after PHA treatment the distal small intestinal weight was increased in comparison to that of the control. In addition, the weights of the stomach, liver, pancreas and proximal small intestine, and the small intestinal length, were increased at 48 h after the PHA treatment. This effect was still evident at 72 h after treatment for all organs, with the exclusion of the stomach (Table 1, Fig. 2) . 
Effects on small intestinal morphology
During the early phase of the observation period, between 1 and 12 h after treatment, villus shortening was evident in the proximal small intestine, and the intestinal diameter had decreased significantly by 6 h after challenge (Table 2) . However, PHA provocation had no effect on the crypts in the proximal small intestine during the first 12 h, and the treatment did not induce any significant changes in the morphology of the distal region of the small intestine during this time. These early effects were followed by intestinal mucosal growth, measured as an increase in intestinal diameter and villi height, crypt size enlargement, and increase in the number of PCNA-stained crypt cells during a later phase. By 24 to 72 h after PHA treatment, the intestinal crypt size (depth and width) was generally enlarged throughout the small intestine. At 24 h, these changes were accompanied by an increase in both the number of PCNA þ enterocytes and the total number of cells per crypt throughout the small intestine (Table 3) . By 72 h after treatment, the villi length of the proximal intestinal region had increased. In the distal small intestine, the vacuolated enterocytes (immature type) were found along the whole villi in the controls (Fig. 3(A) ), while in the PHA-exposed rats, a replacement of these enterocytes by cells lacking the supranuclear vacuoles (adult type) was apparent at the base of the villi at 72 h, with the remaining vacuolated cells found to be restricted to the upper half of the villi (Fig. 3(B) ).
Effects on intestinal function
The intestinal macromolecular absorption capacity, as determined by plasma concentrations of the marker molecules BSA and BIgG, did not change in the control animals during the observation period (Table 4) . However, treatment with PHA had already markedly reduced the plasma concentrations of BIgG and BSA at 1 h after treatment, and the macromolecular absorption capacity remained noticeably reduced during the entire observation period in these animals. In addition, the activities of the brush-border disaccharidases, lactase, maltase and sucrase, in the proximal small intestinal region were affected in the PHA-fed pups. The lactase activity showed a decrease by 3 h after exposure, and was significantly lowered between 6 and 48 h after exposure, but then began to increase and was almost restored to pre-treatment levels by 72 h (Fig. 4(A) ). The maltase and especially the sucrase activities were low in the controls rats at this time, but similar to the lactase activity, the maltase activity showed a significant decrease at 6-12 h due to the PHA treatment (Fig. 4(B and C) ). However, both the maltase and sucrase activities began to increase noticeably after this time period, and were considerably enhanced compared with control levels by 48 and 72 h after treatment.
Effect on the pancreas
During the first 12 h, PHA treatment appeared to lead to a decrease in the total pancreas protein content and the contents of the individual enzymes, trypsin and amylase, but the changes in enzyme contents were not statistically significant until after 24 h (Fig. 5) . However, after this, the protein and trypsin contents after PHA treatment were greater than those in controls by 48 h and amylase by 72 h. Control  8·3  2·3  ND  ND  ND  10·6  2·0  ND  11·3  2·8  PHA  8·8  1·8  ND  ND  12·8  2·7  13·2**  3·1  ND  11·5  2·2  Total number of crypt cells  Control  15·9  1·2  ND  ND  ND  17·1  1·7  ND  21·1  3·4  PHA  16·5  2·0  ND  ND  20·3  2·3  22·6***  2·9  ND  23·1  2·4 ND, not determined. Mean values were significantly different, PHA-treated rats v. their respective time-matched controls (unpaired t test): **P,0·01, ***P,0·001.
Effects on plasma hormone concentrations
The total plasma corticosterone concentration was significantly elevated compared with that of the controls by 6 h after the PHA treatment, but not thereafter. In contrast, the plasma concentrations of insulin were unaffected by the challenge during the entire observation period (Table 5) .
Discussion
The major finding of the present study was that the provocation of 14-d-old suckling rats with a single orogastric dose of PHA had profound morphologic and functional effects on the gastrointestinal tract. During the early phase, up to approximately 24 h after gavage feeding, the PHA bound along the gut lining, resulting in a disturbed morphology and an affected function. During the subsequent phase over the following two days, the PHA binding to the gastrointestinal mucosa declined. Moreover, it became evident that gastrointestinal growth had been stimulated and the gastrointestinal function appeared more adult-like.
Early (1 -24 h) effects of phytohaemagglutinin treatment
The results confirmed that PHA binds rapidly to the gastrointestinal mucosa after exposure in the suckling rats. The PHA staining was intense and confined to the small intestinal brush-border region during the first 24 h; after which a translocation of the PHA to the cytoplasmic granules of the enterocytes and to the lamina propria was observed. These results indicated that PHA is endocytosed and passes over the mucosal barrier, and may thereafter reach the systemic circulation.
In fact, studies on adult rats have shown that 5-10 % of the orogastrically administered PHA reached the blood circulation (Pusztai, 1989 (Pusztai, , 1993 . On the other hand, it was not possible, using immunohistochemical methods, to detect any PHA present in the extraintestinal organs studied, the pancreas, liver, thymus or spleen, which contradicted the possibility that PHA was taken up to the blood circulation and had a direct interaction with these organs. In addition to a tendency for a reduced weight of the small intestine, morphological changes such as a decrease in the small intestinal diameter and a shortening of the villi were evident. This indicated that there had been a decrease in the intestinal surface area in the proximal small intestine during this early phase. Also the fluid accumulation, indicative of a secretory response, and general appearance of the gut at necroscopy indicated a temporary mucosal disarrangement and a disruption of the gut due to the exposure to PHA.
In parallel to this, the intestinal function became affected. The intestinal absorption of both the receptor-mediated (FcgRn) uptake of the immunoglobulin marker BIgG, and the more unspecific marker BSA, showed a rapid decrease. In addition, the activities of the intestinal brush-border enzymes, lactase and maltase, declined markedly. This rapid effect on intestinal function could be coupled to the disruption and shortening of the intestinal enterocyte villi, probably in combination with a disarrangement and vesiculation of the microvilli (King et al. 1980; Weinman et al. 1989; Hagen et al. 1994) . This would lead to a decrease in the brush- Fig. 3 . Photomicrographs from the distal small intestine illustrating enterocytes containing supranuclear vacuoles ( " ), 72 h after gavage feeding a single dose of phytohaemagglutinin (PHA) or saline (control) to 14-d-old suckling rats. The supranuclear vacuoles are restricted to the upper half of the villi in PHA-treated rats (B), as opposed to the controls (A), where enterocytes containing vacuoles are found along the entire villi, from the base to the top. Table 4 . Plasma levels of the marker molecules, bovine IgG (BIgG) and bovine serum albumin (BSA), 3 h after administration of the markers (by gavage feeding) to 14-d-old suckling rats that had been gavage-fed a single dose of phytohaemagglutinin (PHA) or saline (control). Marker molecule solutions were administered at various times from 1 to 72 h after treatment with PHA or saline (Mean values and standard deviations for five to seven determinations) border enzyme activity and would almost block the transcytotic capacity. An alternative explanation to the decreased macromolecular absorption could be that PHA, bound to the mucosa, might prevent the macromolecules from attaching to the intestinal wall, a prerequisite for adsorptive endocytosis.
The present results also showed that PHA exposure affected the pancreas, an organ not in direct continuity with the PHAexposed gut in the suckling rats. Treatment led to a decrease in the enzyme contents during the early phase, indicating that pancreatic secretion had been stimulated. This observation agreed with data indicating that PHA given orally to adult rats stimulated pancreatic enzyme secretion to the duodenum, an effect that in part was mediated via a cholecystokinindependent pathway (Herzig et al. 1997; Grant et al. 1999 Grant et al. , 2000 Pusztai, 1999) . Although not specifically investigated in the present study, this effect might be explained by an indiscriminate binding of PHA to the intestinal cells, including the enteroendocrine peptide-releasing cells, resulting in a release of various pancreas-stimulating hormones.
Late (24-72 h) effects of phytohaemagglutinin treatment
During this later phase, the PHA binding had subsided or disappeared, but a strong growth-promoting effect on the gastrointestinal tract was now generally observed, as shown by the increased proliferation of small intestinal crypt cells, the enlarged villi and crypts, and heavier organ weights compared with the controls. This prominent growth-promoting effect agreed with the observations of previous studies on suckling rats that had received PHA for a 3 d period, as well as those of other studies on PHA-treated adult rats (Pusztai et al. 1990; Banwell et al. 1993; Herzig et al. 1997; Linderoth et al. 2005) .
Already by 24 h after PHA gavage feeding, gut function appeared to be partially restored, and over the following two days showed an alteration in function in comparison to that shown by the controls. This was accompanied by a change from a neonatal phenotype of disaccharidase expression to resemble that of an adult phenotype, with a striking increase in the maltase and sucrase activities. In addition, the macromolecular absorptive capacity was considerably reduced, which also agreed with the presence of an adult-like phenotype, i.e. with intestinal closure that normally occurs at weaning, at 3 weeks of age.
In addition it was noted that, by 48 -72 h after challenge, the PHA treatment had stimulated pancreas growth and maturation, as the total pancreas protein content and the pancreatic enzyme contents had increased. It was likely that PHA exposure affected pancreas growth and function in part as a result of the release of gut-stimulating hormones, e.g. cholecystokinin (Herzig et al. 1997; Grant et al. 1999; Pusztai, 1999) . Moreover, glucocorticoids, thyroxine and insulin have been suggested to be involved in pancreatic development in the rat (Henning, 1987; Puccio et al. 1988; Kinouchi et al. 1998) . Accordingly, since the corticosterone concentration was increased, this hormone might have contributed to the stimulatory effect on the pancreas after the PHA treatment.
Possible mediators/pathways of regulation
The results showed that PHA treatment led to an increase in plasma corticosterone concentration during the early phase (1-24 h), implying that this hormone was involved in the induction of the maturation-like effects on the gastrointestinal tract. Glucocorticoids have previously been shown to be involved in gastrointestinal maturation in rats (Puccio et al. 1988; Martin et al. 1993; Henning et al. 1994; Polk & Barnard, 2000; Biol-N'garagba et al. 2003) . In fact, during normal postnatal development, the concentration of circulating glucocorticoids has been observed to increase approximately 2 d prior to the initiation of the functional changes that occur around weaning, such as the changes in pancreatic and intestinal digestive enzyme activities and the cessation of intestinal macromolecular absorption (Henning et al. 1994; Polk & Barnard, 2000) . Exogenous administered glucocorticoids are also known to be capable of eliciting the precocious expression of sucrase activity and the disappearance of the neonatal FcgRn (Yeh et al. 1989; Martin et al. 1993; Henning et al. 1994; Pacha, 2000) . Then again, several studies have supported the presence of a glucocorticoid-independent pathway in gastrointestinal maturation (Henning et al. 1994; Pacha, 2000) , and some studies have demonstrated that endogenous adrenal steroids were not entirely responsible for the age-dependent decline of IgG transport (Martin et al. 1993) . In addition, neither adrenalectomy nor the administration of glucocorticoid antagonists could totally abolish intestinal maturation (Henning et al. 1994; Nanthakumar & Henning, 1995; Pacha, 2000) .
Insulin and insulin-like growth factor have also been suggested to be involved in gastrointestinal maturation (Young et al. 1990; Kinouchi et al. 1998 Kinouchi et al. , 2000 Polk & Barnard, 2000) . PHA has been shown to have an insulin-mimicking effect in vitro and, in fact, after long-term exposure to PHA in the adult rat, insulin plasma concentrations showed a decrease (Pusztai & Watt, 1974; Pusztai et al. 1995; Bardocz et al. 1996) . In the light of this, it would be possible that PHA could elicit some of its effects on gut maturation by mimick- ing these hormones. However, the present data indicated that PHA exposure did affect plasma concentrations of insulin, suggesting that insulin was not involved in the PHA-induced maturation of the suckling rat.
In conclusion, in suckling rats exposure to PHA initially disrupts the gut, with mucosal disarrangement and functional impediment as a consequence. This initial effect is, however, temporary, and during a later phase a stimulatory response of the gut to the PHA can be observed, characterized by increased growth and induced maturation of the gastrointestinal tract and pancreas function. This is manifested by an alteration in the enterocyte phenotype, from a neonatal to a more adult one, with changed disaccharidase pattern, a decrease in macromolecular absorptive capacity, and displacement of the supranuclear vacuole-containing enterocytes. Binding of PHA to the intestinal villi, with a subsequent acceleration of cell turnover and increase in plasma corticosterone concentrations, appears to be involved in the mechanism of these actions. These findings may lead to a better understanding of the role of diet in gastrointestinal maturation and may constitute a basis for the treatment of mammals having an immature gut.
